Published in NPJ Parkinsons Dis on January 14, 2016
Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism | NCT03446807
Top Altmetric Scores in the Parkinson's Disease Literature. J Parkinsons Dis (2017) 0.75
The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol (1989) 13.32
The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res (1995) 9.99
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord (2009) 3.56
Prediagnostic presentations of Parkinson's disease in primary care: a case-control study. Lancet Neurol (2014) 3.50
Fatigue in neurological disorders. Lancet (2004) 3.45
Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord (2002) 3.00
Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer (2008) 2.89
Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol (2005) 2.81
The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun (2006) 2.40
Mechanisms of cancer-related fatigue. Oncologist (2007) 2.25
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med (2009) 1.91
A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. J Clin Psychiatry (2006) 1.90
Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology (2013) 1.68
Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord (2001) 1.64
Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord (2011) 1.62
Fatigue in Parkinson's disease: a review. Mov Disord (2007) 1.53
Fatigue in early Parkinson's disease. Minor inconvenience or major distress? Eur J Neurol (2012) 1.47
Fatigue in Parkinson's disease. Neurology (1993) 1.46
Attending to the task: interference effects of functional tasks on walking in Parkinson's disease and the roles of cognition, depression, fatigue, and balance. Arch Phys Med Rehabil (2004) 1.44
Bedside-to-Bench conference: research agenda for idiopathic fatigue and aging. J Am Geriatr Soc (2010) 1.41
Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biol Res Nurs (2009) 1.36
Loneliness predicts pain, depression, and fatigue: understanding the role of immune dysregulation. Psychoneuroendocrinology (2012) 1.26
The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study). Mov Disord (2014) 1.21
Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. Brain (2010) 1.17
Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology (2003) 1.16
The Parkinson fatigue scale. Parkinsonism Relat Disord (2005) 1.13
Fatigue in levodopa-naive subjects with Parkinson disease. Neurology (2008) 1.13
Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst (2013) 1.11
Reduction of serotonin transporters of patients with chronic fatigue syndrome. Neuroreport (2004) 1.11
Is fatigue an independent and persistent symptom in patients with Parkinson disease? Neurology (2004) 1.11
Multiple sclerosis-associated fatigue. Expert Rev Neurother (2010) 1.11
Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study. Mov Disord (2003) 1.09
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord (2010) 1.09
Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1993) 1.05
Physical and mental fatigue in Parkinson's disease: epidemiology, pathophysiology and treatment. Drugs Aging (2009) 1.05
Fatigue in Parkinson's disease: a nine-year follow-up. Mov Disord (2001) 0.99
Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial. Mov Disord (2007) 0.98
Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment. Brain Behav Immun (2013) 0.96
Fatigue in patients with Parkinson's disease. Behav Neurol (2000) 0.94
Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr Cancer Ther (2009) 0.92
Fatigue in Parkinson's disease. Expert Opin Pharmacother (2011) 0.90
Perceptions of effort during handgrip and tongue elevation in Parkinson's disease. Parkinsonism Relat Disord (2005) 0.90
Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease. J Appl Physiol (1985) (2014) 0.90
Prevalence of fatigue in Parkinson disease and its clinical correlates. Neurology (2014) 0.89
Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability. JAMA Neurol (2015) 0.88
Non-motor symptoms of Parkinson's disease A review…from the past. J Neurol Sci (2014) 0.88
Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson's disease? Mov Disord (2011) 0.87
Pupillary unrest correlates with arousal symptoms and motor signs in Parkinson disease. Mov Disord (2011) 0.87
Validation of the Modified Fatigue Impact Scale in Parkinson's disease. Parkinsonism Relat Disord (2012) 0.86
Levodopa normalizes exercise related cortico-motoneuron excitability abnormalities in Parkinson's disease. Clin Neurophysiol (2003) 0.84
Change in intraindividual variability over time as a key metric for defining performance-based cognitive fatigability. Brain Cogn (2014) 0.83
The association between fatigue and apathy in patients with either Parkinson's disease or multiple sclerosis. Parkinsonism Relat Disord (2015) 0.83
The associations between fatigue, apathy, and depression in Parkinson's disease. Acta Neurol Scand (2014) 0.82
Effects of endurance exercise training on the motor and non-motor features of Parkinson's disease: a review. J Parkinsons Dis (2015) 0.81
Interventions for fatigue in Parkinson's disease: A systematic review and meta-analysis. Mov Disord (2014) 0.80
Effects of an adapted physical activity program on motor and non-motor functions and quality of life in patients with Parkinson's disease. NeuroRehabilitation (2014) 0.80
The importance of unresolved fatigue in depression: costs and comorbidities. Psychosomatics (2014) 0.79
Perceived fatigue is comparable between different disease groups. QJM (2009) 0.79
Effect of exercise on motor and nonmotor symptoms of Parkinson's disease. Parkinsons Dis (2015) 0.79
Nonpharmacologic approach to fatigue in patients with cancer. Cancer J (2014) 0.79
Fatigue. Med Clin North Am (2014) 0.78
Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS. Parkinsonism Relat Disord (2014) 0.77
Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol (2008) 1.21
Does vagotomy reduce the risk of Parkinson's disease? Ann Neurol (2015) 1.06
Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease. Mov Disord Clin Pract (2016) 0.75
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers. Ann Neurol (2022) 0.75
Neuropsychological correlates of multiple sclerosis across the lifespan. Mult Scler (2015) 0.75